Avrobio | Capitaux Propres Et Réserves

Equity Capital And Reserves Changement Date
Adcock Ingram Holdings ZAR 5.39B 88.26M 2023-06
Akebia Therapeutics USD -30584000 8.84M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Celltrion KRW 16.98T 12.65T 2023-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Ecofibre AUD 74.63M 19.27M 2023-06
Gilead Sciences USD 22.75B 435M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Kangmei Pharma CNY 6.8B 24.71M 2023-09
Knight Therapeutics CAD 814.66M 7.47M 2023-09
Laboratorios Farma EUR 516.64M 3.37M 2023-06
Malin Corporation EUR 96.2M 186.9M 2023-06
Medical Developments International AUD 81.32M 7.06M 2023-06
Neuren Pharmaceuticals AUD 91.51M 49.92M 2023-06
Organigram Holdings CAD 301.99M 207.11M 2023-03
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pfizer USD 96.93B 2.08B 2023-09
Pharma Mar EUR 206.2M 4.11M 2023-09
Probiotec AUD 87.14M 4.89M 2023-06
Qiagen NV USD 3.69B 70.09M 2023-09
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Sartorius EUR 2.07B 30.4M 2023-09
Sino Biopharmaceutical CNY 29.99B 242.26M 2023-06
Takeda JPY 7.07T 149.3B 2023-09
Zz Pientze Pharmaceu 13.01B 877.71M 2023-09



Avrobio Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.